糖尿病患者精细降糖治疗策略病例分析PPT课件.ppt

糖尿病患者精细降糖治疗策略病例分析PPT课件.ppt

  1. 1、本文档共33页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
糖尿病患者精细降糖治疗策略病例分析PPT课件

Case 3 Highlights 对于胰岛素作用与胰岛素分泌均存在明显障碍的患者,应注意在改善胰岛素抵抗的同时使用胰岛素补充治疗。 联合使用二甲双胍与胰岛素是这类患者的最佳选择。 谢 谢! * Normally, insulin secretion can be divided into two basic components, basal and stimulated. Basal insulin is secreted continuously between meals and throughout the night, reduces hepatic glucose production. In diabetic patients, treatment with intermediate-acting or long-acting insulin attempts to mimic the basal secretory pattern. Stimulated insulin secretion occurs in response to a meal and results in insulin concentrations of 60 to 80 mU/L from just before to 30 minutes after the meal. Concentrations return to basal levels in 2 to 4 hours. Regimens of regular insulin attempt to mimic the stimulated insulin secretory pattern. * Normally, insulin secretion can be divided into two basic components, basal and stimulated. Basal insulin is secreted continuously between meals and throughout the night, reduces hepatic glucose production. In diabetic patients, treatment with intermediate-acting or long-acting insulin attempts to mimic the basal secretory pattern. Stimulated insulin secretion occurs in response to a meal and results in insulin concentrations of 60 to 80 mU/L from just before to 30 minutes after the meal. Concentrations return to basal levels in 2 to 4 hours. Regimens of regular insulin attempt to mimic the stimulated insulin secretory pattern. 与开始胰岛素治疗患者的早期类似实验结论一样,增加Lantus?的剂量可能会引起夜间低血糖症。 * * Tier 1: well-validated core therapies These interventions represent the best established and most effective and cost- effective therapeutic strategy for achieving the target glycemic goals. The tier one algorithm is the preferred route of therapy for most patients with type 2 diabetes. Tier 2: less well-validated therapies In selected clinical settings, this secondtier algorithm may be considered. When hypoglycemia is particularly undesirable , the addition of exenatide or pioglitazone may be considered. Rosiglitazone is not recommended. If promotion of wei

文档评论(0)

dajia1qi + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档